Citations

Citations to this article as recorded by  

• Radiotherapy dose may not affect prognosis in ESCC patients receiving first-line chemoradiotherapy-immunotherapy: A multicenter retrospective study
  Jingyuan Wen, Xinyi Liu, Yuanji Xu, Zhongmei Lin, Min Hou, Yan Gui, Jianzhong Cao, Qing Hou, Jiahua Lv, Lulu Wang, Wei Zhou, Zhimin Zeng, Wenbin Shen
  Cancer Immunology, Immunotherapy.2026;[Epub]     CrossRef
• Current and future on definitive concurrent chemoradiotherapy for inoperable locally advanced esophageal squamous cell carcinoma
  Renxian Xie, Qingxin Cai, Tong Chen, Hongxin Huang, Chuangzhen Chen
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Expert consensus on radiotherapy for elderly patients with esophageal cancer in China (2024 edition)
  
  Radiation Medicine and Protection.2024; 5(4): 268.     CrossRef
• Involved‐field high‐dose chemoradiotherapy with respiratory motion management for esophageal squamous cell carcinoma
  Masaki Matsuda, Takafumi Komiyama, Kan Marino, Shinichi Aoki, Tomoko Akita, Naoki Sano, Hidekazu Suzuki, Masahide Saito, Hikaru Nemoto, Hiroshi Onishi
  Thoracic Cancer.2024; 15(33): 2365.     CrossRef
• The impact of radiation dose on the efficacy of definitive chemoradiotherapy in patients with locally advanced esophageal carcinoma: a systematic review and meta-analysis
  Danjing Luo, Qiulu Zhong, Xiaodong Zhu
  Cancer Biology & Therapy.2023;[Epub]     CrossRef
• High-Dose Versus Standard-Dose Intensity-Modulated Radiotherapy With Concurrent Paclitaxel Plus Carboplatin for Patients With Thoracic Esophageal Squamous Cell Carcinoma: A Randomized, Multicenter, Open-Label, Phase 3 Superiority Trial
  Jing You, Shuchai Zhu, Jiancheng Li, Jie Li, Junyue Shen, Yidian Zhao, Xiaomin Li, Lin Jia, Qingshan Li, Jun Yang, Yiqun Wu, Wenbin Shen, Haishan Wu, Xueqin Wu, Xiaomin Wang, Yaqiong Ren, Jun He, Pingping Lin, Guangying Zhu, Anhui Shi
  International Journal of Radiation Oncology*Biology*Physics.2023; 115(5): 1129.     CrossRef
• Chemoradiotherapy Combined with Brachytherapy for the Definitive Treatment of Esophageal Carcinoma
  Julian Mangesius, Katharina Hörmandinger, Robert Jäger, Sergej Skvortsov, Marlen Plankensteiner, Martin Maffei, Thomas Seppi, Daniel Dejaco, Matthias Santer, Manuel Sarcletti, Ute Ganswindt
  Cancers.2023; 15(14): 3594.     CrossRef
• Do higher radiation doses improve survival for cervical esophageal squamous cell cancer patients treated with definitive chemoradiotherapy using intensity-modulated radiotherapy? A propensity-score matched analysis
  Feihong Xie, Tingting Liu, Xinran Wang, Jinling Dong, Wei Huang, Hongfu Sun
  Journal of Cancer Research and Therapeutics.2023; 19(6): 1582.     CrossRef
• Is Escalated Radiation Dose in Definitive Chemoradiotherapy Better for Inoperable Esophageal Carcinoma? A Meta-Analysis and Systematic Review
  Xiaochuan Gan, Qitao Gou, Jing Zhu, Tao Zhang
  Advances in Bioscience and Biotechnology.2023; 14(04): 172.     CrossRef
• Intensity-modulated radiotherapy with more than 60 Gy improved the survival of inoperable patients with locally advanced esophageal squamous cell carcinoma
  Wei Zhang, Qing Xie, Bifa Zhu, Xiaokang Wang, Ling He, Yong Zhang
  Medicine.2022; 101(16): e29166.     CrossRef
• A Phase III Multicenter Randomized Clinical Trial of 60 Gy versus 50 Gy Radiation Dose in Concurrent Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma
  Yujin Xu, Baiqiang Dong, Weiguo Zhu, Jiancheng Li, Rong Huang, Zongwen Sun, Xinmei Yang, Liping Liu, Han He, Zhongxing Liao, Ni Guan, Yue Kong, Wanwei Wang, Jianxiang Chen, Huijuan He, Guoqin Qiu, Ming Zeng, Juan Pu, Wangyuan Hu, Yong Bao, Zhigang Liu, Ju
  Clinical Cancer Research.2022; 28(9): 1792.     CrossRef
• Comparative clinical studies of primary chemoradiotherapy versus S-1 and nedaplatin chemotherapy against stage IVb oesophageal squamous cell carcinoma: a multicentre open-label randomised controlled trial
  Yun Liu, Narasimha M Beeraka, Junqi Liu, Kuo Chen, Bo Song, Zhang Song, Jianchao Luo, Yang Liu, Anping Zheng, Yanhui Cui, Yang Wang, Zhenhe Jia, Xiangyu Song, Xiaohong Wang, Hongqi Wang, Xuefeng Qi, Jinshan Ren, Liping Wu, Jixing Cai, Xainying Fang, Xin W
  BMJ Open.2022; 12(4): e055273.     CrossRef
• A Novel Model Combining Tumor Length, Tumor Thickness, TNM_Stage, Nutritional Index, and Inflammatory Index Might Be Superior to the 8th TNM Staging Criteria in Predicting the Prognosis of Esophageal Squamous Cell Carcinoma Patients Treated With Definitiv
  Xiaohui Chen, Yilin Yu, Haishan Wu, Jianjian Qiu, Dongmei Ke, Yahua Wu, Mingqiang Lin, Tianxiu Liu, Qunhao Zheng, Hongying Zheng, Jun Yang, Zhiping Wang, Hui Li, Lingyun Liu, Qiwei Yao, Jiancheng Li, Wenfang Cheng
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Comparison of involved-field intensity-modulated radiotherapy combined with S-1 vs radiotherapy alone for elderly patients with esophageal cancer
  Li-Hua Liu, Mao-Hui Yan, Yu-Peng Di, Zhi-Guang Fu, Xiao-Dan Zhang, Hong-Qi Li
  World Journal of Clinical Cases.2022; 10(21): 7365.     CrossRef
• A combined predicting model for benign esophageal stenosis after simultaneous integrated boost in esophageal squamous cell carcinoma patients (GASTO1072)
  Weitong Liu, Chengbing Zeng, Siyan Wang, Yizhou Zhan, Ruihong Huang, Ting Luo, Guobo Peng, Yanxuan Wu, Zihan Qiu, Derui Li, Fangcai Wu, Chuangzhen Chen
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Definitive chemoradiotherapy for clinical T4b esophageal cancer – Treatment outcomes, failure patterns, and prognostic factors
  Tzu-Ting Huang, Shau-Hsuan Li, Yen-Hao Chen, Hung-I Lu, Chien-Ming Lo, Fu-Min Fang, Shang-Yu Chou, Yi-Chun Chiu, Yeh-Pin Chou, Yu-Ming Wang
  Radiotherapy and Oncology.2021; 157: 56.     CrossRef
• Feasibility and Oncological Outcome of Preoperative Chemoradiation With IMRT Dose Intensification for Locally Advanced Esophageal and Gastroesophageal Cancer
  Roberto Innocente, Federico Navarria, Roberto Petri, Elisa Palazzari, Massimo Vecchiato, Jerry Polesel, Antonio Ziccarelli, Antonio Martino, Paolo Ubiali, Dino Tonin, Andrea Lauretta, Claudio Belluco, Luisa Foltran, Angela Buonadonna, Arben Lleshi, Carlot
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Radiation Therapy
  K. Jingu, R. Umezawa, T. Yamamoto, Y. Ishikawa, N. Takahashi, K. Takeda, Y. Suzuki, S. Teramura, S. Omata
  Nihon Kikan Shokudoka Gakkai Kaiho.2021; 72(2): 84.     CrossRef
• Randomized Study on Dose Escalation in Definitive Chemoradiation for Patients With Locally Advanced Esophageal Cancer (ARTDECO Study)
  Maarten C. C. M. Hulshof, Elisabeth D. Geijsen, Tom Rozema, Vera Oppedijk, Jeroen Buijsen, Karen J. Neelis, Joost J. M. E. Nuyttens, Maurice J. C. van der Sangen, Paul M. Jeene, Jannie G. Reinders, Mark I. van Berge Henegouwen, Adriana Thano, Jeanin E. va
  Journal of Clinical Oncology.2021; 39(25): 2816.     CrossRef
• Esophageal Cancer Radiotherapy Dose Escalation Meta Regression Commentary: “High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis”
  Ronald Chow, Michael Lock, Sangjune Laurence Lee, Simon S. Lo, Charles B. Simone
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Conformal radiation therapy versus volumetric arc therapy in high dose concurrent chemoradiotherapy for carcinoma esophagus
  Tapas Kumar Dora, Jayashree Deshmukh, Abhishek Chatterjee, Alok Goel, Subhadeep Bose, Avtar Singh, Amit Saini, Shefali Pahwa, Sarbani Ghosh Laskar, Jai Prakash Agarwal, Shyam Kishore Shrivastava, Rakesh Kapoor
  Cancer Research, Statistics, and Treatment.2021; 4(3): 456.     CrossRef
• Phase II Trial of Epigallocatechin-3-Gallate in Acute Radiation-Induced Esophagitis for Esophagus Cancer
  Xiaoling Li, Ligang Xing, Yujun Zhang, Peng Xie, Wanqi Zhu, Xiangjiao Meng, Yinxia Wang, Lingling Kong, Hanxi Zhao, Jinming Yu
  Journal of Medicinal Food.2020; 23(1): 43.     CrossRef
• Intensity-Modulated Radiotherapy versus Three-Dimensional Conformal Radiotherapy in Definitive Chemoradiotherapy for Cervical Esophageal Squamous Cell Carcinoma: Comparison of Survival Outcomes and Toxicities
  Nai-Bin Chen, Bo Qiu, Jun Zhang, Meng-Yun Qiang, Yu-Jia Zhu, Bin Wang, Jin-Yu Guo, Ling-Zhi Cai, Shao-Min Huang, Meng-Zhong Liu, Qun Li, Yong-Hong Hu, Qi-Wen Li, Hui Liu
  Cancer Research and Treatment.2020; 52(1): 31.     CrossRef
• High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis
  Xin Sun, Lei Wang, Yang Wang, Jingjing Kang, Wei Jiang, Yu Men, Zhouguang Hui
  Frontiers in Oncology.2020;[Epub]     CrossRef
• Stage III Esophageal Squamous Cell Carcinoma Patients With Three-Dimensional Conformal or Intensity-Modulated Radiotherapy: A Multicenter Retrospective Study
  Qin Qin, Xiaolin Ge, Xin Wang, Lan Wang, Chen Li, Junqiang Chen, Xiaomin Wang, Yidian Zhao, Wencheng Zhang, Ping Wang, Qingsong Pang, Kaixian Zhang, Ling Li, Miaomiao Hu, Chongli Hao, Gaofeng Li, Yonggang Xu, Xueying Qiao, Zhiguo Zhou, Shuchai Zhu, Wenbin
  Frontiers in Oncology.2020;[Epub]     CrossRef
• High‐dose versus standard‐dose radiation therapy for cervical esophageal cancer: Retrospective single‐institution study
  Tae Hyung Kim, Ik Jae Lee, Ji‐Hyun Kim, Chang Geol Lee, Yong Chan Lee, Jun Won Kim
  Head & Neck.2019; 41(1): 146.     CrossRef
• Relationship Between Sarcopenia and Prognosis in Patient With Concurrent Chemo-Radiation Therapy for Esophageal Cancer
  Dae Won Ma, Yeona Cho, Mi-jin Jeon, Jie-Hyun Kim, Ik Jae Lee, Young Hoon Youn, Jae Jun Park, Da Hyun Jung, Hyojin Park, Chang Geol Lee, Jun Won Kim, Hei Cheul Jeung
  Frontiers in Oncology.2019;[Epub]     CrossRef
• Different prognosis of patients with esophageal carcinoma with M1a and regional node involvement
  Tae Ryong Chung, Jie-Hyun Kim, Ik Jae Lee, Yeona Cho, Jun Won Kim, Chang Geol Lee, Da Hyun Jung, Jae Jun Park, Young Hoon Youn, Hyojin Park
  Digestive and Liver Disease.2019; 51(11): 1610.     CrossRef
• Effect of modern high-dose versus standard-dose radiation in definitive concurrent chemo-radiotherapy on outcome of esophageal squamous cell cancer: a meta-analysis
  He-San Luo, He-Cheng Huang, Lian-Xing Lin
  Radiation Oncology.2019;[Epub]     CrossRef
• Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer
  Dawei Chen, Hari Menon, Vivek Verma, Steven N. Seyedin, Jaffer A. Ajani, Wayne L. Hofstetter, Quynh-Nhu Nguyen, Joe Y. Chang, Daniel R. Gomez, Arya Amini, Stephen G. Swisher, Mariela A. Blum, Ahmed I. Younes, Hampartsoum B. Barsoumian, Jeremy J. Erasmus,
  JAMA Oncology.2019; 5(11): 1597.     CrossRef
• Prognostic value of tumor length and diameter for esophageal squamous cell cancer patients treated with definitive (chemo)radiotherapy: Potential indicators for nonsurgical T staging
  Hongyao Xu, Shengxi Wu, Hesan Luo, Chuyun Chen, Lianxing Lin, Hecheng Huang, Renliang Xue
  Cancer Medicine.2019; 8(14): 6326.     CrossRef
• Prognostic impact of postoperative pulmonary complications following salvage esophagectomy after definitive chemoradiotherapy
  Masaru Hayami, Masayuki Watanabe, Naoki Ishizuka, Shinji Mine, Yu Imamura, Akihiko Okamura, Takanori Kurogochi, Kotaro Yamashita
  Journal of Surgical Oncology.2018; 117(6): 1251.     CrossRef
• Definite intensity‐modulated radiotherapy with concurrent chemotherapy more than 4 cycles improved survival for patients with locally‐advanced or inoperable esophageal squamous cell carcinoma
  He‐Yuan Hsieh, Chung‐Ping Hsu, Hui‐Ling Yeh, Cheng‐Yen Chuang, Jai‐Fu Lin, Chen‐Fa Chang
  The Kaohsiung Journal of Medical Sciences.2018; 34(5): 281.     CrossRef
• Comparison of definite chemoradiation therapy with carboplatin/paclitaxel or cisplatin/5-fluoruracil in patients with squamous cell carcinoma of the esophagus
  Stefan Münch, Steffi U. Pigorsch, Michal Devečka, Hendrik Dapper, Wilko Weichert, Helmut Friess, Rickmer Braren, Stephanie E. Combs, Daniel Habermehl
  Radiation Oncology.2018;[Epub]     CrossRef
• Definitive radiotherapy dose escalation with chemotherapy for treating non-metastatic oesophageal cancer
  Chao-Yueh Fan, Yu-Fu Su, Wen-Yen Huang, Hsing-Lung Chao, Kuen-Tze Lin, Chun-Shu Lin
  Scientific Reports.2018;[Epub]     CrossRef
• The role of definitive chemoradiation in patients with non-metastatic oesophageal cancer
  Paul M. Jeene, Hanneke W.M. van Laarhoven, Maarten C.C.M. Hulshof
  Best Practice & Research Clinical Gastroenterology.2018; 36-37: 53.     CrossRef
• Nedaplatin‑based chemotherapy regimens combined with concurrent radiotherapy as first‑line treatment for stage II‑III esophageal squamous cell carcinoma
  Huiping Zhu, Xiaolin Ge, Yufeng Lu, Yun Zuo, Qin Qin, Xinchen Sun, Min Yang
  Oncology Letters.2018;[Epub]     CrossRef
• Improved survival with higher radiation dose for esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy
  Yuxia Deng, Chao Bian, Hua Tao, Haijun Zhang
  Oncotarget.2017; 8(45): 79662.     CrossRef

Citations

Citations to this article as recorded by  

• Efficacy of Pd-1/Pd-L1 Inhibitors in Advanced Gastroesophageal Cancer Based on Characteristics: A Meta-Analysis
  Wenjie Liu, Gengwei Huo, Peng Chen
  Immunotherapy.2023; 15(10): 751.     CrossRef
• Gastric Cancer in Older Patients: A Retrospective Study and Literature Review
  Yonghoon Choi, Nayoung Kim, Ki Wook Kim, Hyeong Ho Jo, Jaehyung Park, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee
  Annals of Geriatric Medicine and Research.2022; 26(1): 33.     CrossRef
• Survival benefits of gastrectomy compared to conservative observation for older patients with resectable gastric cancer: a propensity score matched analysis
  Shuhei Ito, Kippei Ohgaki, Tetsuro Kawazoe, Huanlin Wang, Toshihiko Nakamura, Shinichiro Maehara, Eisuke Adachi, Yoichi Ikeda, Yoshihiko Maehara
  Langenbeck's Archives of Surgery.2022; 407(6): 2281.     CrossRef
• Current therapeutic options for gastric adenocarcinoma
  C.R. Akshatha, Smitha Bhat, R. Sindhu, Dharini Shashank, Sarana Rose Sommano, Wanaporn Tapingkae, Ratchadawan Cheewangkoon, Shashanka K. Prasad
  Saudi Journal of Biological Sciences.2021; 28(9): 5371.     CrossRef
• Utility of monthly minodronate for osteoporosis after gastrectomy: Prospective multicenter randomized controlled trials
  Masashi Hirota, Tsuyoshi Takahashi, Yurina Saito, Ryohei Kawabata, Rie Nakatsuka, Hiroshi Imamura, Masaaki Motoori, Yoichi Makari, Atsushi Takeno, Kentaro Kishi, Shinichi Adachi, Hiromichi Miyagaki, Yukinori Kurokawa, Makoto Yamasaki, Hidetoshi Eguchi, Yu
  Annals of Gastroenterological Surgery.2021; 5(6): 754.     CrossRef
• Is surgery the best treatment for elderly gastric cancer patients?
  Yoshihiko Kawaguchi, Hidenori Akaike, Katsutoshi Shoda, Shinji Furuya, Naohiro Hosomura, Hidetake Amemiya, Hiromichi Kawaida, Hiroshi Kono, Daisuke Ichikawa
  World Journal of Gastrointestinal Surgery.2021; 13(11): 1351.     CrossRef
• The role of surgery in patients aged 85 years or older with resectable gastric cancer: a propensity score matching analysis of the SEER database
  Jing Guo, Junhui Yu, Zhengshui Xu, Xuejun Sun, Jianbao Zheng
  Scandinavian Journal of Gastroenterology.2020; 55(6): 694.     CrossRef
• Elderly patients with cancer admitted to intensive care unit: A multicenter study in a middle-income country
  Antonio Paulo Nassar Junior, Mariane da Silva Trevisani, Barbara Beltrame Bettim, Fernando Godinho Zampieri, José Albani Carvalho, Amilton Silva, Flávio Geraldo Rezende de Freitas, Jorge Eduardo da Silva Soares Pinto, Edson Romano, Silvia Regina Ramos, Gu
  PLOS ONE.2020; 15(8): e0238124.     CrossRef
• Optimal treatment for elderly patients with resectable proximal gastric carcinoma: a real world study based on National Cancer Database
  Xuefei Wang, Junjie Zhao, Mark Fairweather, Tingsong Yang, Yihong Sun, Jiping Wang
  BMC Cancer.2019;[Epub]     CrossRef
• Hypermethylated long noncoding RNA MEG3 promotes the progression of gastric cancer
  Lei Ding, Yuan Tian, Ling Wang, Miaomiao Bi, Dengke Teng, Sen Hong
  Aging.2019; 11(19): 8139.     CrossRef
• Age does not influence efficacy of ramucirumab in advanced gastric cancer: Subgroup analyses of REGARD and RAINBOW
  Kei Muro, Jae Yong Cho, Gyorgy Bodoky, Chanchal Goswami, Yee Chao, Lucas V dos Santos, Yasuhiro Shimada, Eldar Topuzov, Eric Van Cutsem, Josep Tabernero, John Zalcberg, Ian Chau, Stefano Cascinu, Rebecca Cheng, Yanzhi Hsu, Michael Emig, Mauro Orlando, Cha
  Journal of Gastroenterology and Hepatology.2018; 33(4): 814.     CrossRef